eXp World Holdings Appoints Interim CFO Amid Leadership Transition
March 17, 2025 - 19:40
BELLINGHAM, Wash. — eXp World Holdings, Inc. has announced the appointment of Jesse Hill as the Interim Chief Financial Officer, effective April 1, 2025. Hill, who currently serves as the Vice President of International Finance and Corporate Financial Planning & Analysis at eXp Realty, steps into this crucial role as the company undergoes a leadership transition.
The decision to appoint Hill reflects the company's commitment to maintaining a strong financial oversight during this period of change. As Interim CFO, he will be responsible for overseeing the financial operations and strategic planning of the organization, ensuring that eXp World Holdings continues to thrive in a competitive market.
Hill's extensive experience in finance and corporate strategy positions him well to guide the company through its current phase. The leadership team and board of directors express confidence in his ability to lead effectively during this transitional period, as the company prepares for future growth and innovation.
MORE NEWS
June 8, 2026 - 22:27
What history tells us about Marvell's upcoming S&P 500 inclusionMarvell Technology shares have been climbing sharply after the announcement that the company will join the S&P 500 index on June 22. Investors are betting that the move will bring fresh demand from...
June 8, 2026 - 04:51
Is PDD Holdings Inc. (PDD) A Good Stock To Buy Now?A recent discussion on a value investing forum laid out a bullish case for PDD Holdings Inc., the parent company of e-commerce platforms Temu and Pinduoduo. As of late May, shares were trading near...
June 7, 2026 - 03:13
Apple Stock: Buy, Sell, or Hold?Apple`s stock is trading close to an all-time high, and a series of potential catalysts could sustain the upward momentum. The company continues to benefit from strong demand for its latest iPhone...
June 6, 2026 - 22:38
Eli Lilly's $3.8 Billion Vaccine Bets: Here's the Big Story Many Investors Are MissingEli Lilly is making a serious push into the vaccine business. The pharmaceutical giant announced a trio of acquisitions totaling $3.8 billion, aimed at building a new division focused on infectious...